Guardian Bio
Guardian Bio is a biotech company in Boston, United States, founded in 2022. It has raised $598K across 2 rounds, most recently a $98K Grant in November 2023.
Dendritic cell-based platform for cancer therapy
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2022
- Website
- guardian-bio.com
- Total Funding
- $598K
- Last Round
- $98K GrantNov 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells sit at the helm of the immune system, directing and dictating immune responses. Data has shown dendritic cells are often dysfunctional in cancer patients, and that this dysfunction is a bottleneck for other therapies. Guardian Bio’s approach is focused on creating a dendritic cell-based product which drives anti-tumor activity through activating the killers of the immune system AND training them against multiple cancer targets. We take stem cells from cancer patients, turn them into specific therapeutic dendritic cells specially trained against that patient’s tumor, and re-introduce them back into the body. Our therapeutic dendritic cells revitalize the killers of the immune system and give them the kickstart they need to fight - and win - against cancer.
Summary
It lists 1–10 employees. It has raised $598K in total across 2 rounds, most recently a $98K Grant round in Nov 2023. Investors include Massachusetts Life Sciences Center and Y Combinator.
Funding History
Nov 2023
Sign up to see all 2 events
Funding: Seed through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/guardian-bio"><img src="https://indexed.vc/api/badge/company/guardian-bio" alt="Guardian Bio on Indexed.vc" width="260" height="76" /></a>